Stock 000411 ZHEJIANG INT'L GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Int'l Group Co.,Ltd.

Equities

000411

CNE0000008D9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 10/05/2024 am IST 		5-day change 1st Jan Change
11.14 CNY -0.89% Intraday chart for Zhejiang Int'l Group Co.,Ltd. +1.00% -0.62%
26/04 Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
19/04 Zhejiang Int'l Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,622 3,030 4,824 3,743 5,814 5,856
Enterprise Value (EV) 1 3,403 3,748 5,617 4,583 6,928 6,792
P/E ratio 28.1 x 18.4 x 30.8 x 23.3 x 17.8 x 10.9 x
Yield 1.03% 0.5% 0.34% 1.36% 1.09% 2.72%
Capitalization / Revenue 0.13 x 0.12 x 0.19 x 0.14 x 0.19 x 0.18 x
EV / Revenue 0.17 x 0.15 x 0.22 x 0.17 x 0.23 x 0.21 x
EV / EBITDA 6.52 x 5.74 x 8.76 x 6.2 x 8.26 x 7.38 x
EV / FCF -23.5 x -11 x -54.9 x 35.1 x 91.1 x -605 x
FCF Yield -4.25% -9.11% -1.82% 2.85% 1.1% -0.17%
Price to Book 2.82 x 2 x 2.91 x 1.97 x 1.72 x 1.38 x
Nbr of stocks (in thousands) 2,48,941 2,98,729 2,98,729 3,06,368 5,02,465 5,22,434
Reference price 2 10.53 10.14 16.15 12.22 11.57 11.21
Announcement Date 25/04/19 25/04/20 23/04/21 19/04/22 28/04/23 19/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 20,492 24,601 25,008 26,731 30,619 32,052
EBITDA 1 522 652.6 641.4 739.1 838.4 920.1
EBIT 1 466.7 578.4 570.2 667.9 763.4 847.8
Operating Margin 2.28% 2.35% 2.28% 2.5% 2.49% 2.65%
Earnings before Tax (EBT) 1 306.6 466.1 466.4 540.6 626.2 801.4
Net income 1 93.85 151.1 156.7 167.8 212.2 488.7
Net margin 0.46% 0.61% 0.63% 0.63% 0.69% 1.52%
EPS 2 0.3750 0.5500 0.5250 0.5250 0.6500 1.030
Free Cash Flow 1 -144.7 -341.4 -102.3 130.6 76.09 -11.23
FCF margin -0.71% -1.39% -0.41% 0.49% 0.25% -0.04%
FCF Conversion (EBITDA) - - - 17.67% 9.08% -
FCF Conversion (Net income) - - - 77.8% 35.85% -
Dividend per Share 2 0.1083 0.0508 0.0542 0.1666 0.1260 0.3045
Announcement Date 25/04/19 25/04/20 23/04/21 19/04/22 28/04/23 19/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 781 719 792 841 1,114 936
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.497 x 1.101 x 1.235 x 1.137 x 1.329 x 1.017 x
Free Cash Flow 1 -145 -341 -102 131 76.1 -11.2
ROE (net income / shareholders' equity) 11.2% 13.4% 11.1% 11.8% 12.5% 13.6%
ROA (Net income/ Total Assets) 3.23% 3.66% 3.24% 3.55% 3.76% 3.91%
Assets 1 2,908 4,130 4,843 4,722 5,651 12,485
Book Value Per Share 2 3.740 5.080 5.560 6.190 6.730 8.140
Cash Flow per Share 2 6.250 5.250 6.100 6.210 2.790 3.080
Capex 1 114 137 178 189 107 168
Capex / Sales 0.56% 0.56% 0.71% 0.71% 0.35% 0.53%
Announcement Date 25/04/19 25/04/20 23/04/21 19/04/22 28/04/23 19/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
ZHEJIANG INT'L GROUP CO.,LTD. Stock Zhejiang Int'l Group Co.,Ltd.
-0.62% 813M
MCKESSON CORPORATION Stock McKesson Corporation
+20.76% 72.16B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-0.82% 23.88B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+8.25% 8.35B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.13% 8.29B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-19.42% 8.18B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+5.56% 4.81B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+16.83% 4.4B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.83% 4B
GALENICA AG Stock Galenica AG
-1.65% 3.92B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 000411 Stock
  4. Financials Zhejiang Int'l Group Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW